Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $377M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELVN | ENLIVEN THERAPEUTICS INC | 5,160,975 | $71.43M | 18.9% | $20.34 | -39.8% | COM | 29337E102 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $66.52M | 17.6% | $17.12 | — | COM | 29384C108 |
| PHVS | PHARVARIS N V | 797,600 | $22.37M | 5.9% | $19.05 | +6.2% | COM | N69605108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 497,270 | $19.72M | 5.2% | $32.09 | -8.3% | COM NEW | 15117B202 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 302,630 | $18.28M | 4.8% | $25.81 | +99.7% | CLASS A ORD | 61559X104 |
| BHVN | BIOHAVEN LTD | 399,972 | $17.12M | 4.5% | $31.10 | 0.0% | COM | G1110E107 |
| IRON | DISC MEDICINE INC | 294,221 | $16.99M | 4.5% | $49.79 | +2.8% | COM | 254604101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,472,264 | $15.31M | 4.1% | $12.62 | -12.4% | COM | 252828108 |
| — | MERUS N V | 521,531 | $14.34M | 3.8% | $27.50 | — | COM | N5749R100 |
| — | VOR BIOPHARMA INC | 6,361,723 | $14.31M | 3.8% | $43.10 | — | COM | 929033108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 586,595 | $12.78M | 3.4% | $17.56 | -10.1% | COM | 92790C104 |
| — | MIRATI THERAPEUTICS INC | 192,500 | $11.31M | 3.0% | $36.13 | — | COM | 60468T105 |
| VKTX | VIKING THERAPEUTICS INC | 585,000 | $10.89M | 2.9% | $14.60 | -10.4% | COM | 92686J106 |
| — | RALLYBIO CORP | 3,630,724 | $8.677M | 2.3% | $17.58 | — | COM | 75120L100 |
| TYRA | TYRA BIOSCIENCES INC | 554,979 | $7.686M | 2.0% | $14.34 | -9.7% | COM | 90240B106 |
| ANAB | ANAPTYSBIO INC | 357,733 | $7.663M | 2.0% | $28.24 | -38.9% | COM | 032724106 |
| — | SCPHARMACEUTICALS INC | 1,200,647 | $7.528M | 2.0% | $5.92 | — | COM | 810648105 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 490,000 | $7.423M | 2.0% | $23.99 | -39.2% | COM | 98943L107 |
| — | SPRUCE BIOSCIENCES INC | 2,364,000 | $6.927M | 1.8% | $2.21 | — | COM | 85209E109 |
| RNAM | AVIDITY BIOSCIENCES INC | 665,555 | $6.023M | 1.6% | $18.92 | -64.7% | COM | 05370A108 |
| COGT | COGENT BIOSCIENCES INC | 790,440 | $4.648M | 1.2% | $6.91 | +10.9% | COM | 19240Q201 |
| — | MERSANA THERAPEUTICS INC | 1,305,000 | $3.028M | 0.8% | $4.03 | — | COM | 59045L106 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $2.758M | 0.7% | $20.70 | — | COM | 438083107 |
| GHRS | GH RESEARCH PLC | 404,404 | $2.346M | 0.6% | $11.07 | -36.2% | ORDINARY SHARES | G3855L106 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $901K | 0.2% | $3.84 | — | COM | 171757107 |